Viewing Study NCT04311957

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2026-02-02 @ 8:57 PM
Study NCT ID: NCT04311957
Status: UNKNOWN
Last Update Posted: 2020-08-03
First Post: 2020-03-15
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults
Sponsor: Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV-1-infection View
None Antiretroviral Therapy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV View
None Second-line therapy View
None Integrase strand transfer inhibitor View
None Protease inhibitor View